OBLN - Obalon Therapeutics EPS of -$0.61 November, 08 2019 07:19 AM Obalon Therapeutics Obalon Therapeutics (NASDAQ:OBLN): Q3 EPS of -$0.61 may not be comparable to consensus of -$5.70.More news on: Obalon Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...